Dillard’s, Inc. Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil prices, Treasury yields remain elevated
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
UBS Reiterates Sell Rating on Dillard's Inc. (DDS)
May 16, 2024 1:59 PM EDTUBS analyst Mauricio Serna reiterated a Sell rating and $192.00 price target on Dillard's Inc. (NYSE: DDS)
The analyst comments "We believe the market was largely focused on DDS' sequential comp sales and gross margin trends relative to Q4. Based on this, we... More
CFRA Reiterates Buy Rating on Dillard's Inc. (DDS)
May 16, 2024 1:44 PM EDTCFRA analyst Zachary Warring reiterated a Buy rating and $500.00 price target on Dillard's Inc. (NYSE: DDS).
The analyst comments "We maintain our 12-month price target of $500, based on 12.5x our FY 25 (Jan.) EPS estimate and lower than the company's 5-year average forward... More
